Free Trial

Ameren Co. (NYSE:AEE) Shares Sold by Natixis

Ameren logo with Utilities background

Natixis lowered its position in Ameren Co. (NYSE:AEE - Free Report) by 89.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 462 shares of the utilities provider's stock after selling 3,790 shares during the period. Natixis' holdings in Ameren were worth $41,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently modified their holdings of AEE. Synergy Investment Management LLC acquired a new stake in shares of Ameren in the 4th quarter worth approximately $25,000. Roxbury Financial LLC purchased a new stake in Ameren during the fourth quarter worth $27,000. Lee Danner & Bass Inc. acquired a new stake in Ameren in the fourth quarter valued at $38,000. ST Germain D J Co. Inc. increased its position in shares of Ameren by 134.5% in the fourth quarter. ST Germain D J Co. Inc. now owns 544 shares of the utilities provider's stock valued at $48,000 after buying an additional 312 shares in the last quarter. Finally, Mather Group LLC. raised its stake in shares of Ameren by 86.2% during the 4th quarter. Mather Group LLC. now owns 540 shares of the utilities provider's stock worth $48,000 after buying an additional 250 shares during the last quarter. 79.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Ameren

In other news, EVP Chonda J. Nwamu sold 5,500 shares of the stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $101.37, for a total value of $557,535.00. Following the completion of the sale, the executive vice president now owns 43,344 shares of the company's stock, valued at $4,393,781.28. This represents a 11.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Shawn E. Schukar sold 4,743 shares of the firm's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $103.79, for a total transaction of $492,275.97. Following the completion of the transaction, the insider now directly owns 57,486 shares in the company, valued at approximately $5,966,471.94. This represents a 7.62 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 12,959 shares of company stock worth $1,316,712 in the last three months. 0.34% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AEE has been the subject of several recent research reports. Evercore ISI upgraded shares of Ameren from an "in-line" rating to an "outperform" rating and raised their target price for the company from $89.00 to $104.00 in a report on Tuesday, January 21st. UBS Group lifted their price objective on Ameren from $106.00 to $113.00 and gave the stock a "buy" rating in a research report on Friday, March 21st. BMO Capital Markets increased their target price on Ameren from $105.00 to $106.00 and gave the company an "outperform" rating in a report on Monday. Barclays cut their price target on Ameren from $102.00 to $101.00 and set an "equal weight" rating for the company in a report on Tuesday, April 8th. Finally, Guggenheim reiterated a "neutral" rating on shares of Ameren in a research report on Tuesday, April 22nd. Four investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $99.33.

View Our Latest Stock Report on Ameren

Ameren Trading Down 0.6 %

Ameren stock traded down $0.64 during trading on Thursday, reaching $98.61. The company had a trading volume of 322,219 shares, compared to its average volume of 1,582,812. Ameren Co. has a 12-month low of $69.39 and a 12-month high of $104.10. The company has a debt-to-equity ratio of 1.41, a quick ratio of 0.44 and a current ratio of 0.66. The stock's 50 day moving average price is $98.65 and its two-hundred day moving average price is $94.03. The firm has a market capitalization of $26.61 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 2.97 and a beta of 0.45.

Ameren (NYSE:AEE - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The utilities provider reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.83 by ($0.06). Ameren had a net margin of 15.51% and a return on equity of 10.34%. During the same quarter in the previous year, the firm earned $0.60 EPS. As a group, equities analysts expect that Ameren Co. will post 4.93 earnings per share for the current fiscal year.

Ameren Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Tuesday, March 11th were paid a dividend of $0.71 per share. The ex-dividend date was Tuesday, March 11th. This is a positive change from Ameren's previous quarterly dividend of $0.67. This represents a $2.84 annualized dividend and a yield of 2.88%. Ameren's dividend payout ratio is currently 64.25%.

Ameren Profile

(Free Report)

Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.

Featured Stories

Institutional Ownership by Quarter for Ameren (NYSE:AEE)

Should You Invest $1,000 in Ameren Right Now?

Before you consider Ameren, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.

While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines